Compare BUD & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BUD | MCK |
|---|---|---|
| Founded | 1366 | 1833 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Other Pharmaceuticals |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.4B | 107.4B |
| IPO Year | N/A | N/A |
| Metric | BUD | MCK |
|---|---|---|
| Price | $64.79 | $819.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $71.50 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 2.1M | 868.8K |
| Earning Date | 10-30-2025 | 02-04-2026 |
| Dividend Yield | ★ 1.50% | 0.40% |
| EPS Growth | N/A | ★ 66.19 |
| EPS | 3.00 | ★ 32.12 |
| Revenue | $58,605,000,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $0.69 | $14.87 |
| Revenue Next Year | $5.47 | $8.32 |
| P/E Ratio | ★ $20.82 | $25.54 |
| Revenue Growth | N/A | ★ 17.23 |
| 52 Week Low | $45.94 | $565.75 |
| 52 Week High | $72.13 | $895.58 |
| Indicator | BUD | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 61.69 | 48.53 |
| Support Level | $64.26 | $801.21 |
| Resistance Level | $65.57 | $824.95 |
| Average True Range (ATR) | 0.87 | 16.74 |
| MACD | 0.34 | -2.27 |
| Stochastic Oscillator | 83.95 | 45.20 |
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.